School of Life & Health Sciences Aston University Aston TriangleBirmingham B4 7ETUK
Email: email@example.com telephone: +44 (0) 121 204 3898fax: +44 (0) 121 204 3892
Member of the Pharmacy and Biology Teaching Programmes
Chronic and Communicable Conditions
Aston Research centre in CHildren and Young people's health(ARCHY)
Professor and Head of Diabetes Research, Aston UniversityFormerly Reader and Senior Lecturer in Pharmacology, and Lecturer in Physiology, Aston University
1998 FRCP, Fellowship, Royal College of Physicians, Edinburgh 1996 FRCPath, Fellowship, Royal College of Pathologists
Diabetes Research at Aston University studies the regulation of nutrient metabolism, the pathogenesis of diabetes mellitus and obesity, and the development of new therapies. Specific interests include:
Bailey CJ. Metformin. In Therapy for Diabetes Mellitus and Related Disorders, 6th edn. Umpierrez GE, ed. American Diabetes Association, Alexandria VA, 2014, pp341-358.
Home P, Riddle M, Cefalu WT, Bailey CJ, Bretzel RG, Del Prato S, Leroith D, Schernthaner G, van Gaal L, Raz I. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes Care 2014, 37, 1499-508.
Rana KS, Arif M, Hill EJ, Aldred S, Nagel DA, Nevill A, Randeva HS, Bailey CJ, Bellary S, Brown JE. Plasma irisin levels predict telomere length in healthy adults. Age 2014, 36, 995-1001.
Ahren B, Gautier JF, Berria R, Aronson R, Bailey CJ. Pronounced reduction of glucagon by lixisenatide: a meta-analysis of randomized clinical trials. Diabetes Obesity Metab 15, in press 2014. Doi 10.111/dom.12290
Qureshi KM, Lee J, Paget MB, Bailey CJ, Curnow SJ, Murray HE, Downing R. Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivity. Cell Transplant 2014 in press
Co-author of Diabetes in Europe Policy Puzzle: The State We Are In, 4th Edition (2014) http://www.idf.org/regions/EUR/policypuzzle
Employable Graduates; Exploitable Research
© Copyright Aston University,
Birmingham, B4 7ET